Debt to Equity Ratio Chart

View Debt to Equity Ratio for IFRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Debt to Equity Ratio Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 0.0057
March 31, 2026 0.0223
September 30, 2025 0.0214
June 30, 2025 0.0105
March 31, 2025 0.01
September 30, 2024 0.0138
June 30, 2024 0.0122
March 31, 2024 0.0117
December 31, 2023 0.0109
September 30, 2023 0.0095
June 30, 2023 0.0094
March 31, 2023 0.0161
December 31, 2022 0.0154
September 30, 2022 0.0146
June 30, 2022 0.0151
March 31, 2022 0.0141
December 31, 2021 0.0136
September 30, 2021 0.0132
Date Value
June 30, 2021 0.013
March 31, 2021 0.0034
December 31, 2020 0.0072
September 30, 2020 0.0071
June 30, 2020 0.008
March 31, 2020 0.0075
December 31, 2019 0.0079
September 30, 2019 0.0073
June 30, 2019 0.0075
March 31, 2019 0.0046
December 31, 2018 0.00
September 30, 2018 0.00
June 30, 2018 0.00
March 31, 2018 0.00
December 31, 2017 0.00
September 30, 2017 -1.589
June 30, 2017 -1.732

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
MediGene AG --
BioNTech SE 0.0178
Immatics NV 0.0365
Beam Therapeutics, Inc. 0.2317
Kymera Therapeutics, Inc. 0.0521